Adaptimmune Therapeutics PLC
NASDAQ:ADAP
Adaptimmune Therapeutics PLC
Total Assets
Adaptimmune Therapeutics PLC
Total Assets Peer Comparison
Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors
Company | Total Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Adaptimmune Therapeutics PLC
NASDAQ:ADAP
|
Total Assets
$258m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Total Assets
$360.2m
|
CAGR 3-Years
213%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Total Assets
$375.4m
|
CAGR 3-Years
8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Total Assets
$547.1m
|
CAGR 3-Years
35%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Total Assets
£597m
|
CAGR 3-Years
45%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
Total Assets
£1.1B
|
CAGR 3-Years
8%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
See Also
What is Adaptimmune Therapeutics PLC's Total Assets?
Total Assets
258m
USD
Based on the financial report for Mar 31, 2024, Adaptimmune Therapeutics PLC's Total Assets amounts to 258m USD.
What is Adaptimmune Therapeutics PLC's Total Assets growth rate?
Total Assets CAGR 5Y
-1%
Over the last year, the Total Assets growth was -10%. The average annual Total Assets growth rates for Adaptimmune Therapeutics PLC have been -14% over the past three years , -1% over the past five years .